Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2003
08/07/2003WO2002072627A3 Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination
08/07/2003WO2002068476A3 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders
08/07/2003WO2002053588A3 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia psittaci
08/07/2003WO2002033119A3 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
08/07/2003WO2002018608A9 Methods for enhancing the efficacy of cancer therapy
08/07/2003WO2002012331A3 Compositions and methods for the therapy and diagnosis of pancreatic cancer
08/07/2003US20030149998 Nucleotide sequences coding orphan receptors/membrane proteins OM-10 and UP-11 for detecting modulators of inflammation, nervous system activity and infection; antitumor/antiinflammatory agents; gene expression inhibition
08/07/2003US20030149531 Serpentine transmembrane antigens expressed in human cancers and uses thereof
08/07/2003US20030149256 Transferrin polynucleotides, polypeptides, and antibodies
08/07/2003US20030149247 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
08/07/2003US20030149246 Macromolecular conjugates and processes for preparing the same
08/07/2003US20030149244 Adjusting affinity of Fab 27/26 fragments/polypeptides generating improved ragweed-induced histamine release inhibition; bronchodilator agents
08/07/2003US20030149242 Novel polypeptide
08/07/2003US20030149237 G-protein coupled receptor for treatment and prevention of eating, cancer, autoimmune, vision and nervous sytem disorders; antiinflammatory agents
08/07/2003US20030149062 Therapy of inflammatory diseases of the airways or intestines which by administering substances selected from quinazoline derivatives, 4-((3-chloro-4-fluorophenyl)amino)-6-((4-dimethylamino-cyclohexyl)amino) -pyrimido(5,4-d)pyrimidine
08/07/2003US20030148990 Administering a therapeutically effective amount of an epidermal growth factor receptor (EGF-R) antagonist for therapy of hypersecretion of mucus in lungs
08/07/2003US20030148986 For therapy of atherosclerosis and other vascular diseases such as thrombosis, restenosis after angioplasty and/or stenting, and vein-graft disease after bypass surgery
08/07/2003US20030148983 Polynucleotide therapy
08/07/2003US20030148982 Bi-spcific chimeric T cells
08/07/2003US20030148972 Hereditary hemochromatosis gene
08/07/2003US20030148951 Human EMR2, a G-protein coupled receptor from the EGF_TM7 family
08/07/2003US20030148947 MIP as a research tool for identification, characterization and purification of molecules involved in cellular transport and osmotic regulation; agonists/antagonists; vision defects; anitinflammatory agents; nervous system and kidney disorders
08/07/2003US20030148920 For inhibiting tumor-induced angiogenesis; antiischemic agents
08/07/2003US20030148522 Equine infectious anemia viral plasmid for transfection of heterologous genes into mammalian cells
08/07/2003US20030148465 Comprises membrane protein for diagnosis and treatment of atherosclerosis, viral and inflammatory diseases
08/07/2003US20030148456 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
08/07/2003US20030148451 Endothelial differntiation gene 6-like g protein coupled receptor
08/07/2003US20030148446 Acute neuronal induced calcium binding protein type 1 ligand
08/07/2003US20030148409 Genetically engineered monoclonal di/tri/tetra antibodies preferential tumor associated antigens for use in diagnosis and treatment of tumors
08/07/2003US20030148408 Compositions and methods for the diagnosis and treatment of tumor
08/07/2003US20030148398 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
08/07/2003US20030148394 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058, or 6351 molecules
08/07/2003US20030148382 PanCAM nucleic acids and polypeptides
08/07/2003US20030148378 Phosphodiesterase 10
08/07/2003US20030148376 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148375 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148373 Comprises nucleotide sequences coding membrane protein/pro-polypeptide; antitumor agents; drug screening
08/07/2003US20030148346 Comprises Staphylococcus aureus virulence genes which target bactericides in assay; drug screening; vaccines
08/07/2003US20030148325 Infectious clones
08/07/2003US20030148306 Aggrecanase molecules
08/07/2003US20030148305 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
08/07/2003US20030148285 Source of Immunodominant MHC-associated Peptides (SIMP); antibodies, probes, and cells, to characterize SIMP, modulate its cellular levels, diagnose and treat cancers and modulate immune response
08/07/2003US20030148271 Given amino acid sequence; expression vectors, host cells; diagnosis, prevention and treatment of diseases associated with expression of the kallikrein
08/07/2003US20030148264 PDZ (PSD-95/Discs large/ZO-I) domains, (PSD-95 = post-synaptic density protein-95); PDZ proteins involved in assembling ion channels and other transmembrane receptors, at specialized subcellular sites such as tight junctions
08/07/2003US20030147978 A vaccine adjuvants and a growth promoter each comprising a sugar cane-derived extract as an active ingredient which agent is safe to man and animals. Also presented are foods and feeds comprising these agents.
08/07/2003US20030147924 Chlamydia antigens and corresponding dna fragments and uses thereof
08/07/2003US20030147923 Composition & corresponding method of using spores of bacillus subtilis to stimulate and/or enhance immune response in mammals
08/07/2003US20030147922 Vaccine against streptococcus pneumoniae capsular polysaccharides
08/07/2003US20030147920 RC-529 (the glucosamine phosphate compound) and QS-21 (a saponin); synergistic mixture; vaccines; treating cancer, microbial infections and autoimmune disorders
08/07/2003US20030147919 Producing empty, and thus non-infectious, parvovirus capsids, and to diagnostic assays and vaccines utilizing same; packaging and transferring nucleic acids
08/07/2003US20030147918 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
08/07/2003US20030147917 Retrovirus from the HIV group and its use
08/07/2003US20030147916 Recombinant influenza a viruses
08/07/2003US20030147915 Antibodies specific for seroreactive regions on HPV 16 proteins E1 and E2
08/07/2003US20030147914 Inactivated, whole or partial Mycoplasma bovis cell and a pharmaceutically acceptable carrier; for cattle
08/07/2003US20030147913 Ehrlichia chaffeensis 28 kDa outer membrane protein multigene family
08/07/2003US20030147912 Use generating immunity to human immunodeficiency virus-1 (HIV); also gene therapy for neurodegenerative disorders; AAV inverted terminal repeats flanking DNA sequences encoding an immunodeficiency virus protein and regulatory sequences
08/07/2003US20030147911 Fusion proteins of mycobacterium tuberculosis antigens and their uses
08/07/2003US20030147910 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
08/07/2003US20030147909 Protein naturally obtained through the activation of the immune system of fish inoculated with the pathogen; for aquaculture
08/07/2003US20030147908 Broad spectrum antagonists and vaccines directed against pyrogenic exotoxins
08/07/2003US20030147905 Administering an oligopeptide for immunotherapy
08/07/2003US20030147903 ABC transport polynucleotides, polypeptides and antibodies
08/07/2003US20030147902 Method of stimulating and immune response by administration of host organisms that express intimin alone of as a fusion protein with one of more other antigens
08/07/2003US20030147900 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes there of
08/07/2003US20030147899 Endogenous hormone adjuvant and uses thereof
08/07/2003US20030147898 Adjuvant formulation comprising a submicron oil droplet emulson
08/07/2003US20030147897 M. tuberculosis antigens
08/07/2003US20030147896 A mixture of seven herbs, extract or chemically synthesized as anticancer agent: Tinospora cordifolia, Chlorphyton borivilianum, Curcuma longa, Asparagus racemosus, Hygrophila auriculata, Achyranthus aspera and Elephantopus scaber
08/07/2003US20030147894 Useful in the field of remedies for myelocytic leukemia; binds to the myeloid cells
08/07/2003US20030147893 Novel human transmembrane 4 superfamily protein
08/07/2003US20030147889 Administering type 1-interferon antibody, for inhibition of prevention of autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes, multiple sclerosis and psoriasis
08/07/2003US20030147888 Polyvalent immunogen
08/07/2003US20030147887 B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies
08/07/2003US20030147884 Administering a breast cancer patient (caused by human ErbB2 oncogene which codes a transmebrane glycoprotein receptor related to epidermal growth factor receptor, is overexpressed) an anti ErbB2 antibody and a drug
08/07/2003US20030147883 Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection
08/07/2003US20030147880 Genetic engineered nucleotide sequences codes a recombinant protein for treating allergy
08/07/2003US20030147875 Sulfatases and methods of use thereof
08/07/2003US20030147872 B lymphocytes treated with an antigen; treating or preventing diseases, a liposome encapsulation
08/07/2003US20030147870 Administering an immunostimulatory nucleic acid molecule to increase an antigen-specific lymphocyte, chemokine for blocking HIV infections
08/07/2003US20030147867 Gene therapy for antagonizing a transforming growth factors-beta; anticarcinogenic agents
08/07/2003US20030147862 Administering a colony stimulating factor and/or a nucleic acids encoding the factor; treating a vascular tumor
08/07/2003US20030147859 Administering to the recipient a dose of cultured cells from the donor, before the transplant surgery; administering antigenic determinant for treating autoimmune disease
08/07/2003US20030147809 Antitumor agents
08/07/2003US20030147806 PSCA: prostate stem cell anitgen and uses thereof
08/07/2003CA2849427A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/07/2003CA2509776A1 Vaccine adjuvant based on a cd40 ligand
08/07/2003CA2474960A1 Mixed haptenized tumor cells and extracts and methods of treating or screening for cancer
08/07/2003CA2474954A1 Treatment of tumor cells for use in immunotherapy of cancer
08/07/2003CA2474908A1 Aggrecanase molecules
08/07/2003CA2474794A1 Method of providing prophylaxis for tuberculosis in hiv positive individuals
08/07/2003CA2474689A1 Drugs ameliorating circadian rhythum disorder
08/07/2003CA2474616A1 Human monoclonal antibodies to prostate specific membrane antigen (psma)
08/07/2003CA2474571A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
08/07/2003CA2474497A1 Compositions and methods related to tim-3, a th1-specific cell surface molecule
08/07/2003CA2474240A1 Novel monoclonal antibody and nematode larval antigens
08/07/2003CA2473810A1 Fgfr agonists
08/07/2003CA2469738A1 Expression vectors encoding epitopes of target-associated antigens and methods for their design
08/07/2003CA2469571A1 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
08/07/2003CA2466025A1 Rsv proteins, antibodies, compositions, methods and uses
1 ... 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 ... 1823